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The nonsense-mediated decay (NMD) pathway subjects mRNAs with premature termination codons (PTCs) to rapid
decay. The conserved Upf1–3 complex interacts with the eukaryotic translation release factors, eRF3 and eRF1, and
triggers NMD when translation termination takes place at a PTC. Contrasting models postulate central roles in PTC-
recognition for the exon junction complex in mammals versus the cytoplasmic poly(A)-binding protein (PABP) in other
eukaryotes. Here we present evidence for a unified model for NMD, in which PTC recognition in human cells is
mediated by a competition between 39 UTR–associated factors that stimulate or antagonize recruitment of the Upf
complex to the terminating ribosome. We identify cytoplasmic PABP as a human NMD antagonizing factor, which
inhibits the interaction between eRF3 and Upf1 in vitro and prevents NMD in cells when positioned in proximity to the
termination codon. Surprisingly, only when an extended 39 UTR places cytoplasmic PABP distally to the termination
codon does a downstream exon junction complex enhance NMD, likely through increasing the affinity of Upf proteins
for the 39 UTR. Interestingly, while an artificial 39 UTR of .420 nucleotides triggers NMD, a large subset of human
mRNAs contain longer 39 UTRs but evade NMD. We speculate that these have evolved to concentrate NMD-inhibiting
factors, such as PABP, in spatial proximity of the termination codon.
Citation: Singh G, Rebbapragada I, Lykke-Andersen J (2008) A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-
mediated mRNA decay. PLoS Biol 6(4): e111. doi:10.1371/journal.pbio.0060111
Introduction
The process of nonsense-mediated decay (NMD) subjects
mRNAs with premature termination codons (PTCs) to rapid
decay. This helps rid the cell of aberrant mRNAs that have
acquired PTCs through mutation or faulty processing [1–3].
Moreover, several lines of evidence suggest that NMD is also
used as a posttranscriptional mechanism of normal gene
regulation [4]. The NMD pathway employs a set of factors that
are conserved amongst eukaryotes. Central to the NMD
pathway is the Upf complex, which consists of the proteins
Upf1, Upf2, and Upf3 [1–3]. The Upf complex interacts with
the eukaryotic translation release factors, eRF3 and eRF1, and
triggers NMD when translation termination takes place at a
PTC [1–3]. In addition, the Smg proteins, which are conserved
in metazoans, regulate Upf1 function by phosphorylation and
dephosphorylation [2,3].
A fundamental question is how mRNAs with PTCs are
distinguished from those with normal termination codons.
Despite the conservation of core NMD factors, contrasting
models have been proposed in mammalian cells as opposed to
other eukaryotes. Evidence in Saccharomyces cerevisiae and in
cell lines from Drosophila melanogaster suggests that termina-
tion codons are recognized as PTCs when positioned too far
upstream of the poly(A) tail [5–7]. This is thought to be a
consequence of an impaired interaction between eRF3 at the
terminating ribosome and factors associated with the normal
39 UTR, including cytoplasmic poly(A)-binding protein
(PABP) [1,5,7], which on mRNAs with regular stop codons
(proximal to the poly(A) tail) stimulates normal translation
termination [8]. Consistent with this model for NMD, termed
the ‘‘faux 39 UTR’’ model [1,7], 39 UTRs of S. cerevisiae and D.
melanogaster mRNAs are generally short, on average ;100 and
;330 nucleotides in length, respectively [9,10]. Interestingly,
recent observations show evidence that cytoplasmic PABP is
not required for the discrimination of normal termination
codons from PTCs in S. cerevisiae [11]. Thus, cytoplasmic PABP
may function redundantly with other 39 UTR–associated
factors to antagonize NMD.
39 UTRs of human mRNAs are on average longer (;750–
800 nucleotides [12]) than those of S. cerevisiae and D.
melanogaster, and current models for NMD in mammalian
cells do not involve the length of the 39 UTR. Rather, the exon
junction complex (EJC), which is deposited 20–25 nucleotides
upstream of mRNA exon-exon junctions after pre-mRNA
splicing [13], is thought to play a central role. A termination
event more than ;30 nucleotides upstream of one or more
EJCs is thought to trigger NMD through EJC-mediated
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PLoS BIOLOGYrecruitment of the Upf complex [2,3]. This is consistent with
observed direct interactions between EJC components and
Upf3 proteins [14–18]. However, the EJC plays no apparent
role in NMD in D. melanogaster [19] or in Caenorhabditis elegans
[20] and no evidence for the existence of an EJC has been
reported in yeast. Nevertheless, a conceptually similar model
to the EJC model was proposed earlier for NMD of the PGK1
mRNA in yeast, in which a ‘‘downstream sequence element’’
(DSE), when present downstream of a termination codon,
promotes NMD through recruitment of the protein Hrp1p,
which interacts with Upf proteins [21,22].
A fundamental difference between the faux 39 UTR and the
EJC/DSE models for NMD is that the EJC/DSE models propose
that NMD-stimulating factors (the EJC and Hrp1p, respec-
tively) trigger NMD when positioned downstream of a
termination codon, whereas the faux 39 UTR model postu-
lates that NMD is caused instead by the absence of NMD-
antagonizing factors, such as cytoplasmic PABP, which
normally positively inﬂuence translation termination and
mRNA stability. Here, we present evidence for a merged
model for NMD in human cells, which likely can be extended
to other eukaryotes. According to this model, PTC recog-
nition is determined by a competition between 39 UTR–
associated factors, which stimulate (including the EJC) or
antagonize (including cytoplasmic PABP) the recruitment of
the Upf complex to the terminating ribosome. Our observa-
tions suggest that the fundamental principles of the NMD
pathway are much more conserved between mammals and
other eukaryotes than previously anticipated.
Results
39 UTR Introns Are Not Sufficient for Triggering Human
NMD
The EJC model for human NMD postulates that any
translation termination event taking place .50–55 nucleo-
tides upstream of an exon-exon junction should result in
NMD. However, during our studies of the human NMD
pathway, we observed that a b-globin mRNA, in which the
adenovirus major late (AdML) intron was inserted into the 39
UTR 175 nucleotides downstream of the normal b-globin
mRNA translation termination codon, did not show enhanced
mRNA decay as compared to the wild-type b-globin mRNA in
human HeLa Tet-off cells (compare Figure 1A and 1B).
Moreover, in contrast to a well-characterized b-globin NMD
substrate, which contains a premature termination codon at
position 39 (b39; Figure 1C), the AdML intron containing b-
globin mRNA is not stabilized when the central NMD factor
hUpf1 is knocked down (Figure 1A, middle panel and Figure
S1) or when a point mutation causes translation termination
to take place downstream of the inserted intron (Figure 1A,
bottom panel). Sequencing of cDNAs derived from the
mRNAs in Figure 1A revealed the expected splicing patterns
(unpublished data). Thus, in contrast to the prediction from
the EJC model for human NMD, the AdML intron is not
sufﬁcient for triggering NMD when positioned in the 39 UTR
of b-globin mRNA, even though the AdML intron has been
previously demonstrated to recruit an EJC [13].
The observation in Figure 1A was surprising, because a b-
globin mRNA in which the MINX-intron had been placed in
the 39 UTR was previously found to cause reduced mRNA
steady-state levels [23]. Therefore, to rule out the possibility
that the observations in Figure 1A represent an unusual
property of the speciﬁc mRNA reporter, we tested two other
substrates. As seen in Figure 1D and 1E, insertion of the
triosephosphate isomerase (TPI) mRNA intron 6 or the AdML
intron, 140 or 149 nucleotides downstream of the termina-
tion codons of b-globin or TPI mRNAs, respectively, failed to
cause hUpf1-dependent mRNA decay, despite the previously
demonstrated ability of each of these introns to recruit an
EJC [13]. Sequencing of cDNAs derived from the tested
mRNAs revealed the expected splicing patterns (unpublished
data), although a minor fraction of the bTPIi6 mRNA fails to
remove the TPI intron (see asterisk in Figure 1D). We
attempted to test the b-globin mRNA with the MINX-intron
in the 39 UTR, which was previously found to accumulate at
reduced steady-state levels as compared to wild-type b-globin
mRNA [23] (construct generously provided by A. Kulozik and
M. Hentze). However, the MINX intron (as well as a number
of other introns tested in this study) failed to be spliced out of
the b-globin mRNA 39 UTR in the HeLa Tet-off cells used
here (unpublished data). We conclude that a 39 UTR intron is
not sufﬁcient to trigger NMD in human cells. This contradicts
an EJC-centric model for human NMD.
Extended 39 UTRs Trigger Human NMD
Our observation that 39 UTR introns are not sufﬁcient for
triggering human NMD spurred us to test whether cytoplas-
mic PABP may antagonize NMD in human cells, as it does in
S. cerevisiae and D. melanogaster. We therefore ﬁrst manipulated
the position of the poly(A) tail relative to the termination
codons of b-globin and TPI reporter mRNAs and tested the
effect on mRNA decay. As seen in Figure 2A and 2B and
Figure S2, artiﬁcial extension of the 39 UTRs of b-globin or
TPI mRNAs (from 292 and 447 nucleotides, respectively, to
846–1,112 nucleotides) through insertion of fragments of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Fig-
ures 2A and S2) or green ﬂuorescent protein (GFP) (Figure
2B) mRNAs results in mRNA destabilization (compare with
Figures 1B and S2, top panel). This is due to NMD because
depletion of the NMD factors hUpf1 or hUpf2 stabilizes the
mRNAs (Figure 2A and 2B and Figures S1 and S2). Moreover,
the introduction of single point mutations in the termination
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Author Summary
The nonsense-mediated mRNA decay pathway is responsible for
rapidly degrading mRNAs with premature termination codons. This
is important because it prevents the production of potentially
deleterious truncated proteins from aberrant mRNAs, such as those
that have undergone erroneous processing. How does the cell
discriminate aberrant mRNAs from those that are normal? Here we
present evidence that in human cells, the targeting of an mRNA to
nonsense-mediated mRNA decay depends on a competition
between proteins associated with the mRNA 39 UTR that stimulate
or antagonize mRNA decay. We show that cytoplasmic poly(A)-
binding protein, a protein associated with the mRNA 39 end poly(A)
tail, antagonizes mRNA decay. By contrast, a protein complex
deposited onto mRNAs upon pre-mRNA splicing, called the exon
junction complex, stimulates mRNA decay. Our observations suggest
that the competition between these proteins, and probably other
unknown proteins with similar activities, determines whether a key
protein complex in the pathway, the Upf complex, is recruited to the
mRNA upon translation termination, which leads to mRNA decay.codons that results in termination on the same mRNAs in
proximity (180–357 nucleotides upstream) of the poly(A) tail,
results in mRNA stabilization (Figure 2A and 2B and S2,
bottom panels). Even though sequencing of cDNAs derived
from the tested mRNAs revealed no cryptic splicing in the
extended 39 UTRs (unpublished data), depletion of the
central EJC component eIF4AIII results in stabilization of
the bGAP mRNA (Figure S3), possibly reﬂecting the ability of
the EJCs in the b-globin mRNA open reading frame to
stimulate translation as has been previously observed [24,25].
Successive shortening of the 39 UTR of the bGAP mRNA
revealed that a 39 UTR as short as 422 nucleotides can trigger
NMD (Figure S4). This is surprising because a large fraction of
human mRNAs contain 39 UTRs longer than 422 nucleotides
[12]. We conclude that artiﬁcially extended 39 UTRs trigger
NMD in human cells. This is consistent with recent reports in
which steady-state levels of PTCs containing TPI, b-globin,
and Ig-l reporter mRNAs lacking 39 UTR introns were
measured [26–28], and with observations using unspliced
Rous sarcoma virus RNAs in chicken cells [29]. Thus 39 UTR
introns are neither necessary (Figure 2) nor sufﬁcient (Figure
1) for human NMD.
An Intron-Less mRNA Can Undergo NMD
Having observed that 39 UTR introns are not required for
NMD, we asked whether a completely intron-less mRNA can
undergo NMD. It was observed previously that introduction
of PTCs in the naturally intron-less Hsp70 and histone H2A
mRNAs does not result in their decreased steady-state levels,
which led to speculations that intron-less mRNAs are immune
to NMD [30]. However, it has been pointed out that wild-type
Figure 1. A3 9 UTR Intron Is Not Sufficient to Trigger NMD
(A–E) Decay assays in human HeLa Tet-off cells for b-globin (A,D) or TPI mRNAs (E) with inserted 39 UTR introns or b-globin wild-type (B) or PTC-39
mutant (C) mRNAs in the presence of Luciferase (Luc) or hUpf1 siRNAs as indicated (knockdown efficiencies are shown in Figure S1). For each panel,
schematics are shown for each tested mRNA below the panels; b-globin or TPI exons are indicated as light-gray bars, introns as lines, AdML exons are
shown in black, and TPIi6 exons are patterned. Numbers above the panels indicate time after transcriptional repression. mRNA half-lives were calculated
by comparison with the constitutively expressed internal control mRNAs (bUAC-GAP or bwt; top panels in each assay) and are given on the right.
doi:10.1371/journal.pbio.0060111.g001
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may thus not be further destabilized by a PTC [5]. We
therefore tested the stability of three naturally occurring
intron-less mRNAs (encoding eRF3b, SFN, and TBCC) and
found that both wild-type and PTC containing versions of
these mRNAs were unstable (;100- to 150-min half-lives,
unpublished data). Thus, mRNA instability may be a general
feature of natural intron-less mRNAs. However, when the
only intron in the Glutathione Peroxidase 1 (GPx1) mRNA is
removed, introduction of a PTC triggers NMD, although not
as efﬁciently as in the presence of the intron (Figure 2C,
compare lower and upper panels). Thus, neither 39 UTR
introns nor internal introns are essential for human NMD.
However, similarly to a previous report [30] we have not been
able to identify a natural human intron-less mRNA for which
NMD could be observed, perhaps due to the observed
inherent instabilities of the tested mRNAs.
Cytoplasmic PABP Antagonizes Human NMD
To more directly test whether cytoplasmic PABP antago-
nizes NMD in human cells, we examined the effect of
positioning cytoplasmic PABP in proximity of a PTC using
two different approaches. First, as seen in Figure 3A and 3B,
when an MS2-PABPC1 fusion protein (PABPC1 is one of ﬁve
human cytoplasmic PABPs [31]) is artiﬁcially tethered down-
stream of a PTC in two different b-globin NMD reporter
mRNAs, a partial rescue of NMD is observed. This rescue is
due to tethered PABPC1, because similar levels of unfused
PABPC1 (Figure 3A) or MS2 coat protein (Figure 3A and 3B)
do not stabilize the mRNAs. Moreover, tethering of the
nuclear poly(A)-binding protein PABPN1 does not rescue
NMD (Figure 3A) even though it is expressed at levels similar
to MS2-PABPC1 (Figure S5). The efﬁciency of the rescue from
NMD by tethered PABPC1 decreases as the MS2 binding sites
are moved more distal to the PTC in the b-globin PTC-39
mRNA (Figure S6).
As a second independent approach to ask whether PABP
can antagonize human NMD, we tested the effect of inserting
a binding site for PABP downstream of the PTCs. As seen in
Figure 3C and 3D, inclusion of a poly-A30-stretch, but not
that of a random 30-nucleotide stretch, 182 or 230
Figure 2. Intron-Less Extended 39 UTRs Trigger NMD in Human Cells
(A and B) mRNA decay assays showing decay rates of b-globin-derived bGAP, bUAC-GAP, bGFP, and bUAC-GFP mRNAs (see schematics below) in human
HeLa Tet-off cells expressing siRNAs against hUpf1, hUpf2, or as a negative control, Luciferase (Luc), as indicated on the left of each panel (knockdown
efficiencies are shown in Figure S1). Constitutively expressed bwt mRNA was used as internal controls for quantification. Numbers above the panels
indicate time after transcriptional repression. Schematics on the bottom show the used constructs with b-globin exons indicated as light-gray bars,
introns as lines, and GAPDH and GFP sequences as dark-gray and dotted bars, respectively. Numbers on the right indicate mRNA half-lives (t1/2;i n
minutes) calculated from the shown experiment. Numbers in parentheses indicate the fold stabilization with standard deviation (n   3) upon hUpf
knockdown as compared to the Luc control.
(C) mRNA decay assays for intron-containing GPx1 mRNA with a PTC (GPx1-UAA) or a GPx1 mRNA with a PTC expressed from an intron-less construct
(GPx1Di-UAA) (see schematics below) in the presence of Luc or hUpf1 siRNAs as indicated on the left. mRNA decay rates for the shown experiments are
given on the right and numbers in parentheses indicate the fold stabilization with standard deviation (n   3) upon hUpf knockdown as compared to
the Luc control.
doi:10.1371/journal.pbio.0060111.g002
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reporter mRNAs, results in partial rescue of NMD. Thus,
similarly to S. cerevisiae [7] and D. melanogaster [5], cytoplasmic
PABP can antagonize NMD in human cells when placed in
proximity of a PTC. Recent observations suggest that while
cytoplasmic PABP can antagonize NMD in S. cerevisiae,i ti s
not required for discriminating a normal mRNA from an
NMD substrate [11]. Attempts at testing whether PABPC1 is
required for preventing NMD in human cells failed because
HeLa Tet-off cells became detached from plates upon short
interfering RNA (siRNA)-mediated PABPC1 depletion (un-
published data).
A Subset of Naturally Occurring Long 39 UTRs Can
Antagonize NMD
Our observations raise the question of whether naturally
occurring mammalian mRNAs with long 39 UTRs, which can
be several kilobases in length, are normal targets of NMD or
whether they have evolved mechanisms to evade the NMD
pathway. We noted that mRNAs identiﬁed by microarray
Figure 3. PABPC1 Antagonizes NMD
(A and B) mRNA decay assays for b39–2xMS2-Ex2 and bGAP-4xMS2 mRNAs (see schematics below; MS2 binding sites indicated as black bars and GAPDH
sequence in dark gray) in HeLa Tet-off cells expressing the MS2 coat protein fused to PABPC1 (MS2-PABPC1) or PABPN1 (MS2-PABPN1) or individual
unfused proteins as indicated on the left of the panels. Constitutively expressed bUAC-GAP or bwt mRNAs were used as internal controls (upper panels).
(C and D) Northern blots showing decay rates of b39 and bGAP mRNAs, with or without A30 or N30 sequences inserted downstream of the PTCs
(schematic below). For all panels (A–D), numbers on the right indicate mRNA half-lives (t1/2; in minutes) calculated from the shown experiments, and
numbers in parentheses indicate the fold stabilization with standard deviation (n   3) as compared with the control experiments shown in the
corresponding top panels.
doi:10.1371/journal.pbio.0060111.g003
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Cytoplasmic PABP Antagonizes Human NMDassays to be upregulated upon hUpf1 knockdown in HeLa
cells [32] contain on average signiﬁcantly longer 39 UTRs than
those mRNAs unaffected by hUpf1 knockdown (Figure S7).
Moreover, the majority of these 39 UTRs (75%) are longer
than the ;420 nucleotides observed here to trigger NMD in
the bGAP reporter mRNA (Figures S4 and S7). It is possible
that at least a subset of these transcripts undergo NMD due to
an increased distance between the termination codon and the
poly(A) tail. Indeed, when the 1,342-nucleotide 39 UTR of one
of these mRNAs, encoding hSmg5, is replaced for the b-
globin 39 UTR (bSmg5), the chimeric mRNA undergoes NMD
(Figure 4, top two panels). Thus, the Smg5 39 UTR stimulates
NMD, and a subset of mRNAs may have evolved long 39 UTRs
to be regulated by the NMD pathway. However, numerous
mRNAs with long 39 UTRs are not upregulated upon hUpf1
knockdown [32] (Figure S7). When the 39 UTRs from two such
mRNAs, Cript1 and Tram1, were inserted into the b-globin
mRNA, no NMD was observed (Figure 4, bottom panels). This
is in sharp contrast to the observations using artiﬁcial long 39
UTRs (compare to Figures 1 and S4) and suggests that the
ability of a subset of endogenous long 39 UTRs to evade NMD
is an acquired property (see Discussion).
A3 9 UTR Intron Can Enhance Human NMD
Our observations that 39 UTR introns are neither necessary
(Figure 2) nor sufﬁcient (Figure 1) for human NMD raises the
question of whether introns play any role in human NMD. We
therefore tested the effect of inserting the AdML intron into
the 39 UTR of an mRNA, which already undergoes NMD due
to an extended 39 UTR. Interestingly, insertion of the AdML
intron downstream of the termination codon of bGAP mRNA
results in enhanced mRNA decay (Figure 5; bGAP-AdML
mRNA). This effect is only observed when the intron is
positioned in the 39 UTR, as insertion of the same intron
upstream of the termination codon (without disrupting the
open reading frame) does not enhance mRNA decay (Figure
5; bAdML-GAP mRNA). Thus, while a downstream intron is
neither sufﬁcient nor necessary for triggering NMD in human
HeLa cells (Figures 1 and 2) [33], it can enhance the
degradation of an mRNA that is already a target of NMD
Figure 4. Normal Long 39 UTRs Can Evade NMD
mRNA decay assays for bSmg5, bTram1, and bCript1 mRNAs (schematics
with the respective 39 UTR lengths are shown below) in the presence of
Luc or hUpf1 siRNAs. mRNA half-lives are given on the right. The number
in parentheses for the bSmg5 mRNAs indicates the fold stabilization with
standard deviation (n   3) upon hUpf knockdown as compared to the
Luc control.
doi:10.1371/journal.pbio.0060111.g004
Figure 5. A3 9 UTR Intron Enhances NMD
Decay assays for bGAP mRNA in the absence or presence of the AdML
intron inserted into the GAPDH sequence or exon 3 as indicated. For
each panel, schematics are shown for each tested mRNA below the
panels; AdML exons are shown in black. mRNA half-lives are given on the
right with the fold enhancement of mRNA decay rates and standard
deviation (n   3) as compared with the control experiment in the top
panel shown in parentheses.
doi:10.1371/journal.pbio.0060111.g005
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Cytoplasmic PABP Antagonizes Human NMDdue to an extended 39 UTR (Figure 5A and 5B). Consistent
with this, the presence of an intron appears to also stimulate
NMD of a PTC containing GPx1 mRNA (Figure 2C).
PABPC1 Can Out-Compete the Interaction between hUpf1
and eRF3 In Vitro
How does cytoplasmic PABP antagonize NMD when
positioned in proximity of the termination codon? Both
cytoplasmic PABP and Upf1 have been previously observed to
stimulate translation termination in yeast cells [8,34] and to
associate with translation release factor eRF3 [35–40]. This
raised the possibility that cytoplasmic PABP inhibits NMD by
preventing Upf1 from interacting with eRF3 and the
terminating ribosome. As seen in the co-immunoprecipita-
tion (co-IP) assays in Figure 6A, endogenous hUpf1 and
PABPC1 can both be observed in complex with eRF3 in
RNase-treated HeLa cell extracts. However, PABPC1 co-IPs
much more efﬁciently than hUpf1 with eRF3 (Figure 6A), in
spite of comparable estimated number of molecules of
cytoplasmic PABP (;8 3 10
6/cell) and hUpf1 (;3 3 10
6/cell)
in HeLa cells [41,42]. Consistent with this, bacterially ex-
pressed GST-tagged eRF3 was found to associate much more
efﬁciently with rabbit reticulocyte-lysate-translated PABPC1
(Kd ; 5 nM) than hUpf1 (Kd . 1 lM) (unpublished data).
To test whether PABPC1 can antagonize the interaction
between eRF3 and hUpf1 in vitro, we immunopuriﬁed
transiently expressed epitope-tagged eRF3, PABPC1, and
hUpf1 proteins from HEK 293T cells and tested the ability of
hUpf1 to associate with eRF3 in the presence of increasing
amounts of PABPC1. As seen in Figure 6B, in contrast to the
negative control protein hnRNP A1, increasing amounts of
PABPC1 efﬁciently prevent the interaction between hUpf1
and eRF3, even when hUpf1 is present in 10- to 40-fold excess
over PABPC1 (Figure 6B, compare lanes 5 and 6 with lanes 4
and 7). Thus, PABPC1 can antagonize the interaction between
hUpf1 and eRF3 in vitro. However, no reduction in the co-IP
efﬁciency between hUpf1 and eRF3 was observed upon
transient over-expression of FLAG-tagged PABPC1 in HeLa
or HEK 293T cells (unpublished data). Thus, either exogenous
PABPC1 failed to express at adequate levels to observe a
competition in cells, or the relation between hUpf1, PABPC1,
and eRF3 is more complex in cells than it is in vitro.
To test whether amino acid residues of eRF3, which are
important for cytoplasmic PABP interaction, are also
Figure 6. PABPC1 Antagonizes the Interaction between eRF3 and hUpf1 In Vitro
(A) Co-IP assays showing the co-IP of endogenous hUpf1 and PABPC1 and HuR proteins with an antibody against eRF3 (a-eRF3; 1%, 3%, 10%, 30%, and
100% of pellet loaded in lanes 4–8, respectively), or pre-immune serum (Pre-I, lane 1) as a control. 3% and 0.6% of the total lysate are shown in lanes 2
and 3, respectively.
(B) In vitro pull-down assays showing anti-FLAG Western blots of pull-down pellets (upper panels) resulting after myc-tagged eRF3 (lanes 4–7) or no
myc-tagged protein (lanes 1–3), immobilized on an anti-myc antibody resin, was incubated with various amounts of FLAG-tagged hUpf1, PABPC1, or
hnRNP A1 as indicated. Estimated amounts of FLAG-tagged proteins in each reaction are given in lM. Bottom panels show 5% of input protein for each
reaction. The asterisk (*) and dagger () on the right indicates likely degradation products of PABPC1 and cross-reacting Myc-eRF3, respectively.
(C) Lanes 1–6: Western blot for exogenously expressed Myc-tagged eRF3 (wt, lanes 1–3) or eRF3 KAKA mutant protein (KAKA, lanes 4–6) that co-IP with
FLAG-tagged PABPC1, hUpf1, or as a negative control, MS2, as indicated above the lanes. Lanes 7–9: Western blot for exogenously expressed Myc-
tagged eRF1 that co-IP with FLAG-tagged eRF3, eRF3 KAKA mutant protein, or as a negative control, MS2, as indicated above the lanes. For all lanes, 5%
of total input extracts are shown in the bottom panels.
doi:10.1371/journal.pbio.0060111.g006
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eRF3 protein (eRF3 KAKA) mutated in four N-terminal
residues that are conserved between cytoplasmic PABP-
binding proteins [38,43]. As seen in the co-IP assays in Figure
6C, the exogenously expressed eRF3 KAKA mutant protein is
equally impaired in interaction with PABPC1 and hUpf1
(Figure 6C, compare lanes 5 and 6 with lanes 2 and 3). As a
control, the mutant eRF3 KAKA protein associates with eRF1
with similar afﬁnity as wild-type eRF3, suggesting that these
mutations do not cause gross structural alterations, although
local changes cannot be ruled out. Thus, hUpf1 and PABPC1
interact with a similar, though not necessarily overlapping
region of eRF3. The ability of PABPC1 to antagonize the
association between hUpf1 and eRF3 in vitro could therefore
be a result of a direct competition for eRF3 binding, or of a
local structural alteration of eRF3 upon PABPC1 binding,
which prevents hUpf1 association.
Discussion
Previous contrasting models for PTC-recognition in NMD
invoke either 39 UTR–associated factors that stimulate NMD,
the EJC in human cells [2,44], and DSE-binding proteins in
yeast [21], or factors that stimulate normal translation
termination and antagonize NMD [1,45]. Our observations,
together with the observations in the paper by Eberle et al.
[46], are consistent with a uniﬁed model for human NMD, in
which the balance between NMD-antagonizing (such as
PABPC1) and NMD-stimulating (such as the EJC) factor(s)
that are associated with the mRNA 39 UTR, determines
whether termination is considered normal or premature
(Figure 7A). According to this model, a translation termi-
nation event proximal to cytoplasmic PABP (Figure 3), or
other unknown NMD-antagonizing factors, precludes the
interaction of hUpf1 with eRF3 (Figure 6C) and thus
prohibits NMD (Figure 7A, top). By contrast, if hUpf1
associates with eRF3, NMD ensues (Figure 7A, bottom). This
occurs when cytoplasmic PABP, or other inhibitory factors,
are spatially distant from the termination event (Figure 2)
and is enhanced when a splicing event downstream of a
termination codon results in deposition of an EJC (Figure 5),
which provides higher afﬁnity for the hUpf complex (Figure
7A, bottom). However, an exon-exon junction in the 39 UTR
is not sufﬁcient for NMD (Figure 1). This suggests that a
proximal cytoplasmic PABP is dominant over 39 UTR exon-
exon junctions, which is consistent with the observation that
the afﬁnity of PABPC1 for eRF3 appears to be several orders
of magnitude higher than that of hUpf1 (Figure 6 and
unpublished data). However, while introns are observed to
only stimulate NMD of the substrates tested in this study, it
cannot be ruled out that a subset of human mRNAs requires
downstream introns for NMD. Previous experiments, in
which EJC or hUpf proteins tethered to an mRNA 39 UTR
were observed to trigger NMD, may have been assisted by the
extended 39 UTRs resulting from insertion of multiple
tethering sites and/or by the recruitment of multiple NMD-
promoting factors [15,17,47–49]. The model depicted in
Figure 7A may be extended to eukaryotes other than
mammals and is consistent with the observation in Drosophila
S2 cells that the decay of an NMD reporter mRNA is inhibited
upon cytoplasmic PABP depletion [5]. In this case it is
predicted that a large subset of normally stable endogenous
mRNAs become NMD substrates, thus out-titrating the NMD
pathway.
How does cytoplasmic PABP antagonize NMD? While
PABPC1 can out-compete the association of hUpf1 with
eRF3 in vitro (Figure 6B), a more complex relationship may
exist between these proteins in the cell. For example, we
failed to observe exogenously expressed PABPC1 out-com-
pete the co-IP of endogenous hUpf1 with eRF3 (unpublished
data). Moreover, in S. cerevisiae, cytoplasmic PABP truncated
of its C-terminal eRF3-interaction region was capable of
suppressing NMD when tethered in proximity of a PTC [7].
However, we found no loss of eRF3-association of a similarly
truncated PABPC1 in co-IP assays between exogenously
expressed human proteins (unpublished data), suggesting
Figure 7. A Competition between Stimulators and Antagonists of Upf Complex Recruitment in Human NMD
(A) A unified model where NMD is determined by the balance between 39 UTR–associated factors that stimulate (such as the EJC) or antagonize (such as
cytoplasmic PABP) recruitment of the hUpf complex (shown as spheres labeled 1–3) to the terminating ribosome.
(B) Mechanisms by which mammalian mRNAs with long 39 UTRs may evade NMD (see Discussion for details).
doi:10.1371/journal.pbio.0060111.g007
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Cytoplasmic PABP Antagonizes Human NMDthat eRF3 may form a complex with PABPC1 through
additional regions. Understanding the speciﬁc mechanism
by which NMD is antagonized by cytoplasmic PABP, and
likely other 39 UTR–associated factors, is an important goal
for future studies and could involve both direct competition
with the Upf complex as well as modulation of the translation
termination event that excludes Upf complex recruitment in
a more indirect manner. Another open question is how the
interplay between eRF3, PABP, and the Upf complex
inﬂuences events downstream of translation termination.
Interestingly, it was previously observed that the interaction
between eRF3 and cytoplasmic PABP stimulates mRNA
deadenylation in yeast [50], and that deadenylation can be
an early step in NMD [51–53]. Clearly, a great deal remains to
be learned about the relationship between eRF3, the Upf
complex, and cytoplasmic PABP and how it controls the fates
of mRNAs after translation termination.
It is likely that 39 UTR–associated factors (indicated by a
question mark in Figure 7A) other than cytoplasmic PABP
can antagonize NMD. This hypothesis is consistent with the
observation that in yeast cells, cytoplasmic PABP is not
required for discriminating tested NMD substrates from their
normal counterparts [11]. An excellent candidate for such an
activity is the yeast protein Pub1p, which has been identiﬁed
as a factor that binds downstream of upstream open reading
frames (uORFs) in GCN4 and YAP1 mRNAs to prevent NMD
[54]. It is possible that Pub1p and factors with similar
activities are found in a subset of normal 39 UTRs. It remains
to be tested whether Pub1p acts on the terminating ribosome
in a manner similar to cytoplasmic PABP. Similarly, factors
other than the EJC could provide an enhanced afﬁnity for the
Upf complex and stimulate NMD. For example, the protein
Hrp1p appears to serve such a role in the yeast PGK1 NMD
substrate [21]. Moreover, human Staufen1 and histone mRNA
stem loop binding protein have been shown to recruit hUpf1
to the 39 UTR of speciﬁc mRNAs to trigger NMD-like mRNA
decay [55,56]. Thus, our observations suggest that the NMD
pathway is much more conserved between mammals and
other eukaryotes than previously appreciated. Nevertheless,
there is evidence that differences exist between yeast and
mammalian cells as to which round of translation can
stimulate NMD [28,57–59].
Our observations suggest that while artiﬁcial long 39 UTRs
trigger NMD (Figure 2), a subset of mRNAs containing long 39
UTRs have evolved mechanisms to evade NMD (Figure 4).
Future studies should reveal the mechanism by which this is
accomplished. This could conceivably be achieved by (i)
induced looping of the 39 UTR, thus placing the poly(A) tail
and cytoplasmic PABP in close spatial proximity to the
translation termination event (Figure 7B, top), or (ii) by
recruitment of factors that antagonize NMD (such as PABPC1
or Pub1p) to the 39 UTR in proximity to the termination
codon (Figure 7B, bottom). The observation that cytoplasmic
PABP alleviates NMD when placed in the vicinity of a PTC
(Figure 3) [5,7,46] and the ﬁnding in the paper by Eberle et al.
that artiﬁcially induced 39 UTR looping rescues reporter
mRNAs with extended 39 UTRs from NMD [46], provides
proof-of-principle evidence for each of these models. The
mechanism by which speciﬁc mRNAs evade the NMD pathway
is an important subject for future investigation and is likely to
vary between individual mRNAs.
After the submission of this paper, we have become aware
of two other studies reporting that cytoplasmic PABP
antagonizes human NMD when placed in proximity to a
PTC [60,61].
Materials and Methods
Plasmid constructs. All plasmid sequences are available upon
request. Plasmids expressing different b-globin reporter mRNAs were
derived from the pcTET2-bwt plasmid that was constructed by
inserting the human b-globin gene between HindIII and ApaI sites of
a pcDNA3-based plasmid containing six copies of the Tet-operator
sequences upstream of the TATA box. For extended 39 UTR
constructs, parts of the GAPDH mRNA coding sequence and the
entire GAPDH 39 UTR (pcTET2-bGAP) or the GFP ORF (pcTET2-
bGFP) were inserted between NotI and XbaI sites of the pcTET2-bwt
plasmid, thus replacing the b-globin 39 UTR. The b-globin stop codon
was mutated to UAC by site-directed mutagenesis to generate
pcTET2-bGAP-UAC and pcTET2-bGFP-UAC. Plasmids expressing
bGAP-UAC-696, bGAP-UAC-485, and bGAP-UAC-422 mRNAs were
generated by site-directed mutagenesis of pcTET2-bGAP-UAC to
introduce a stop codon (UAA) in the GAPDH sequence, respectively,
696, 485, or 422 nucleotides upstream of the polyadenylation site.
The plasmid expressing bwt mRNA was described earlier [47]. To
construct plasmids expressing b39–2xMS2-Ex2, b39–2xMS2-Ex3, and
b39–2xMS2-3UTR, the 2xMS2 cassette from the previously described
plasmid pcb-2bs [47] was inserted into the BamHI, EcoRI, or NotI
sites, respectively, of the pPC-b39 plasmid described earlier [62]. A
stretch of A30 (pPC-b39-A30)o rN 30 (pPC-b39-N30) was inserted into
the BamHI site of pPC-b39 plasmid using annealed DNA oligos.
Similarly, A30 (pcTET2-bGAP-A30)o rN 30 (pcTET2-bGAP-N30) was
inserted into the XbaI site of the pcTET2-bGAP plasmid. To
construct the pcTET2-bGAP-4xMS2 plasmid, four MS2 binding sites
were ampliﬁed from a previously described plasmid pcb-4bs [47] and
inserted into the XbaI site of pcTET2-bGAP. Plasmids expressing
bAdML, bAdML-UAC, and bTPIi6 mRNAs were constructed by
cloning the AdML intron or TPI intron 6 (TPIi6) and ﬂanking exon
sequences into the XbaI site in pcTET2-bwt or pcTET2-bwt-UAC
plasmids. bGAP-AdML and bAdML-GAP mRNA– expressing plasmids
were constructed by inserting the same AdML intron into XbaI and
EcoRI sites, respectively, in the pcTET2-bwtGAP plasmid. Plasmids
expressing chimeric b-globin mRNAs with 39 UTRs from Smg5,
Cript1, and Tram1 genes, the respective 39 UTRs, were cloned into
the NotI-XbaI sites of pcTET2-bwt.
Plasmids expressing TPI reporter mRNAs were constructed by
inserting the entire human TPI gene between HindIII and XbaI sites
of the pcTET2 plasmid. A NotI site was inserted into exon 6 (in a
manner that preserved the encoded protein) by site-directed muta-
genesis. Codon 189 was mutated to TGA using site-directed muta-
genesis to generate pcTET2-TPI-189. To remove intron 6, a NotI-
XbaI fragment containing exon6-intron6-exon7 was replaced by the
same region ampliﬁed from TPI cDNA, to generate pcTET2-TPIDi6–
189. To extend the TPI 39 UTR, a fragment containing part of the
GAPDH coding region and 39 UTR was inserted into the NotI site of
pcTET2-TPIDi6–189 to generate pcTET2-TPIDi6–189-GAP, or into
the NotI site of pcTET2-TPIDi6 to give rise to pcTET2-TPIDi6-GAP.
TPI-AdML mRNA–expressing plasmid was constructed by inserting
the AdML intron and ﬂanking exonic sequences into the XbaI site of
pcTET2-TPI.
The plasmid expressing intron-containing GPx1 mRNA with a PTC
(pPC-GPx1-UAA) was described earlier [18]. GPx1 cDNA (HindIII-
XbaI) sequence replaced the intron-containing sequence in pPC-
GPx1Di-UAA.
The constructs for knockdowns were based on the pSHAG plasmid
(a gift from Dr. G. Hannon) and contained inserts expressing
precursors to hUpf1, hUpf2, or eIF4AIII siRNAs described earlier
[63,64].
Plasmids expressing FLAG-hUpf1, FLAG-PABPC1, FLAG-hnRNP
A1, and Myc-hnRNP A1 were described earlier [47,62]. pcDNA3-Myc-
eRF3 was constructed by inserting the ORF of eRF3 (longer isoform)
between BamHI and NotI sites of the pcDNA3-Myc vector previously
described [65]. pcDNA3-Myc-eRF3 KAKA was prepared using site-
directed mutagenesis (the mutations are: L66K, N69A, A70K, F73A).
pcDNA3-MS2-FLAG-PABPC1 or pcDNA3-MS2-FLAG-PABPN1 were
obtained by inserting PABPC1 and PABPN1 cDNAs, respectively,
into BamHI-NotI sites of pcDNA3-MS2-FLAG described previously
[62].
NMD factor knockdown. NMD factor knockdowns were performed
by co-transfecting cells with reporter mRNA plasmids and plasmids
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60 h before pulse-chase mRNA decay assays were carried out.
mRNA decay assays and Northern blots. mRNA decay assays were
performed in HeLa Tet-off cells in DMEM/10% FBS/tetracycline (50
ng/ml) transfected with b-globin mRNA expression plasmids. For
each 2-cm well of HeLa Tet-off cells, 10 ng of pcbGo rp c bwt (as an
internal control) and 0.2 lg of tetracycline-regulated reporter mRNA
expression plasmids were co-transfected using TransIT HeLa
Monster reagent (Mirus). For knockdowns, 0.5 lg of pSHAG plasmids
were co-transfected. In each transfection, empty pcDNA3 vector was
added to 1 lg of total plasmid. 36–40 h after transfection, or
approximately 60 h in the case of knockdowns, transcription of
reporter mRNAs was induced by removal of tetracycline through
washing cells with 1 ml of phosphate-buffered saline (PBS) and
adding DMEM/10% FBS. 6 h later, transcription was shut off by
adding tetracycline to a ﬁnal concentration of 1 lg/ml. Cells were
washed with 1 ml PBS and taken up in 500 ll of TRIzol (Invitrogen)
starting 30 min after tetracycline addition (0 min time point), and
subsequently at time points indicated in each ﬁgure. For analysis of
knockdown of endogenous hUpf1, hUpf2, and eIF4AIII, 0.2 lg of the
plasmid pSUPERpuro was co-transfected instead of the plasmids
expressing b-globin mRNA, and cells were treated and harvested as
described earlier [66]. Total cellular RNA was isolated and analyzed
by Northern blots as described earlier [47]. The anti-sense RNA
probe used for b-globin mRNA detection was described earlier [47].
Northern blots for exogenously expressed TPI mRNAs were probed
using UltraHyb reagent following the manufacturer’s protocol
(Ambion), with a short anti-sense RNA probe complementary to
the bovine growth hormone 39 UTR sequence encoded from the
pcDNA3 plasmid. GPx1 mRNAs were probed as described earlier
[18].
Antibodies and Western blots. Rabbit polyclonal anti-sera raised
against eIF4AIII (amino acids 1–41), hUpf1 (amino acids 1–416),
hUpf2 (C-terminal 206 amino acids), and hUpf3b (full-length) were
described earlier [18,47]. Monoclonal mouse antibodies were com-
mercially obtained (anti-FLAG M2, Sigma; anti-Myc 9B11, Cell
Signaling). Monoclonal mouse anti-HuR antibodies were described
earlier [67]. Rabbit polyclonal eRF3 (#ab-49878) and mouse mono-
clonal PABPC1 (#ab-6125–100) antibodies were from Abcam.
Immunoprecipitation assays. In immunoprecipitations shown in
Figure 6B, HEK 293T cells were transiently transfected in 3.5-cm
plates with plasmids expressing FLAG-hUpf1 (0.4 lg), FLAG-PABP1
(0.5 lg), or FLAG-MS2 (0.5 lg), 0.5 lg of plasmid expressing wild-type
or mutant Myc-eRF3 and 0.1 lg of pcDNA3-Myc-hnRNP A1. Empty
pcDNA3 plasmid was added to each transfection to a total of 2 lg. 36–
40 h post-transfection, cells were lysed in 400 ll of hypotonic gentle
lysis buffer (10 mM Tris-HCl [pH 7.5], 10 mM NaCl, 2 mM EDTA,
0.5% Triton X-100, 1.0 mM phenylmethylsulfonyl ﬂuoride, 1 lg/ml of
aprotinin, and 1 lg/ml of leupeptin) for 10 min on ice. NaCl was
added to 150 mM, and RNase A was added to 125 lg/ml. The extracts
were incubated on ice for 5 min and cell debris was removed by
centrifugation. RNase-treated lysed cell extracts were incubated for 2
ha t48C with 40 ll anti-FLAG M2 agarose (Sigma). The beads were
washed eight times with NET-2 (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 0.05% Triton X-100) and the FLAG-tagged protein was eluted
off the beads by gently shaking the beads for 2 h at 4 8Ci n2 0llo f
NET-2 containing 200 lg/ml of FLAG peptide. Immunoprecipitates
separated by SDS-PAGE were probed with anti-Myc 9B11 monoclonal
antibody (Cell Signaling) at a 1:1,000 dilution.
Co-IPs between wild-type or KAKA-mutant eRF3 and eRF1 were
performed as described above from the cells co-transfected with 0.5
lg of plasmids expressing FLAG-tagged proteins (eRF3, eRF3-KAKA,
or MS2 as control), 0.5 lg of plasmids expressing Myc-eRF1, and 0.1
lg of Myc-hnRNP A1 expressing plasmid. Endogenous eRF3 IPs
(Figure 6A) were performed as described above except that ;2.5 3
10
7 HeLa cells were lysed in 1 ml hypotonic gentle lysis buffer, and
the lysates were incubated with 10 lg of anti-eRF3 rabbit polyclonal
antibody (Abcam), or rabbit pre-immune serum as control, pre-
conjugated to 5 mg of protein-A sepharose beads (GE Healthcare).
In vitro competition assay. Approximately 10
7 HEK293T cells from
a 10-cm plate expressing Myc-eRF3, or Myc-peptide as a negative
control, were lysed in 1 ml hypotonic gentle lysis buffer as described
above. The RNase A–treated, cleared extracts were subsequently
incubated with 40 ll anti-Myc resin (Sigma) at 4 8C for 2–3 h,
following which the beads were washed eight times with 1 ml of NET-
2 buffer. The beads were divided into eight equal parts, and indicated
amounts of FLAG-hUpf1, FLAG-PABP1, or FLAG-hnRNP A1
proteins, which had each been afﬁnity-puriﬁed from RNase A–
treated HEK293T cell extracts (protein concentrations estimated by
comparison in anti-FLAG Western blot to a GST-FLAG fusion
protein of known concentration), were incubated in 50 ll of NET-2
supplemented with 0.1 mg/ml BSA and 0.2 mg/ml FLAG peptide. The
reactions were gently shaken at 4 8C for 2–3 h following which the
beads were washed eight times with 1 ml of NET-2 buffer. The beads
were resuspended in 25 ll of SDS-loading buffer (10 mM Tris-HCl
[pH 6.8], 2% SDS, 10% glycerol, 0.5% bromophenol blue, and 50 mM
DTT), and 10 ll of the protein sample was resolved on SDS-PAGE
followed by Western blot analysis using anti-FLAG M2 antibody
(Sigma, 1:1,000 dilution).
Supporting Information
Figure S1. Knockdown Efﬁciencies of NMD and EJC Factors
Western blots showing the efﬁciency of knockdown of hUpf1 (lanes 5
and 11), hUpf2 (lane 6), and eIF4AIII (lane 12). Protein levels are
compared to 100%, 50%, 25%, and 10% of cell extract from cells
expressing an siRNA against F-Luciferase (lanes 1–4 and 7–10).
hUpf3b levels served as a loading control.
Found at doi:10.1371/journal.pbio.0060111.sg001 (1.4 MB TIF).
Figure S2. An Extended 39 UTR in TPI mRNA Triggers NMD
mRNA decay assays showing decay rates of TPI mRNAs with different
length 39 UTRs, due to insertion of a fragment of GAPDH mRNA (see
schematics below), in human HeLa Tet-off cells co-expressing siRNAs
targeting hUpf1 or Luciferase (Luc; as a control) as indicated.
Constitutively expressed bwt mRNA was used as an internal control
for quantiﬁcation. Numbers indicated above the panels indicate time
after transcriptional repression. Schematics on the bottom show the
used construct with TPI exons indicated as light-gray bars (not to
scale), introns as lines, and GAPDH sequences as dark-gray bars.
PTC(189) refers to a PTC at codon 189. Numbers on the right indicate
mRNA half-lives (t1/2; in minutes) calculated from the shown
experiment with the average fold increase and standard deviation
over the half-life of TPI-189Di6-GAP mRNA in the presence of Luc
siRNA calculated from three or more experiments given in
parentheses below.
Found at doi:10.1371/journal.pbio.0060111.sg002 (5.1 MB TIF).
Figure S3. bGAP mRNA Is Stabilized by Knockdown of the EJC
Factor eIF4AIII
mRNA decay assays showing decay rates of the b-globin-derived
bGAP mRNA with an extended 39 UTR in human HeLa Tet-off cells
knocked down (using RNAi) for eIF4AIII, or as a negative control,
Luciferase (Luc), as indicated on the left of each panel (the
knockdown efﬁciency for eIF4AIII is shown in Figure S1). Con-
stitutively expressed bwt mRNA was used as an internal control for
quantiﬁcation. The mRNA half-lives are shown on the right, and the
average fold increase in comparison to the Luc control is given with
standard deviation in parentheses below.
Found at doi:10.1371/journal.pbio.0060111.sg003 (1.6 MB TIF).
Figure S4. Minimal 39 UTR Length That Can Trigger NMD of b-
globin mRNA
Northern blots showing the decay rates of bGAP or bGAP-UAC
mRNAs with successively shorter 39 UTRs. The siRNAs co-expressed
are indicated on the left. The mRNA half-lives are given on the right
in minutes. The schematics of the pre-mRNAs from which the
reporter mRNAs are derived are given below each panel with the
distance between the termination codon and the poly(A) tail
indicated.
Found at doi:10.1371/journal.pbio.0060111.sg004 (1.1 MB TIF).
Figure S5. Exogenously Expressed PABPs Express at Comparable
Levels
Western blots showing expression levels of different FLAG-tagged
proteins expressed in Figure 3A. Endogenous HuR protein serves as a
loading control. The asterisks (*) indicate likely degradation products
of MS2-PABPN1.
Found at doi:10.1371/journal.pbio.0060111.sg005 (1.7 MB TIF).
Figure S6. Proximal Recruitment of PABPC1 Rescues b39 mRNA
from NMD More Efﬁciently as Compared to More Distally Recruited
PABPC1
Northern blots showing the decay rates of b39 mRNAs with 2XMS2
binding sites at different positions downstream of the PTC (shown in
the schematic below). The exogenously expressed proteins are
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Cytoplasmic PABP Antagonizes Human NMDindicated on the left. The decay rates and fold change as compared to
the control (expression of MS2 alone) are given with standard
deviation (n ¼ 3) on the right.
Found at doi:10.1371/journal.pbio.0060111.sg006 (5.6 MB TIF).
Figure S7. 39 UTRs of mRNAs Upregulated Upon hUpf1 Knockdown
Are Longer than Average
Cumulative histograms showing the distribution of the estimated
lengths of 83 human intron-less (black solid line) 39 UTRs from
mRNAs upregulated upon hUpf1 knockdown, as compared to the 39
UTR lengths of 83 randomly selected mRNAs not regulated by hUpf1
(dashed line). The table shows the median 39 UTR length and percent
of mRNAs with 39 UTRs . 420 nt for upregulated and control
mRNAs.
Found at doi:10.1371/journal.pbio.0060111.sg007 (9.2 MB TIF).
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